|
104
|
316
|
6y03A |
Structure of human aldose reductase mutant l300/301a with a citrate molecule bound in the anion binding pocket |
|
103
|
316
|
6t27A |
Structure of human aldose reductase mutant l301a with a citrate molecule bound in the anion binding pocket |
|
105
|
316
|
6t5gA |
Structure of human aldose reductase mutant l300a with a citrate molecule bound in the anion binding pocket |
|
104
|
316
|
6t7qA |
Human aldose reductase mutant l301a in complex with a ligand with an idd structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid) |
|
105
|
316
|
6t3pA |
Human aldose reductase mutant l300a in complex with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) |
|
104
|
316
|
6td8A |
Human aldose reductase mutant l301a in complex with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) |
|
101
|
313
|
6tucA |
Human aldose reductase in complex with alr25 |
|
104
|
316
|
6tufA |
Human aldose reductase in complex with alr43 |
|
104
|
316
|
6txpA |
Human aldose reductase mutant l300a in complex with a ligand with an idd structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid) |
|
106
|
329
|
5zcmA |
Crystal structure of xylose reductase from debaryomyces nepalensis in complex with nadp-dtt adduct |
|
101
|
320
|
5zciA |
Crystal structure of apo form of xylose reductase from debaryomyces nepalensis |
|
106
|
316
|
6f81A |
Akr1b1 at 0.75 mgy radiation dose. |
|
106
|
314
|
6f8oA |
Akr1b1 at 3.45 mgy radiation dose. |
|
106
|
316
|
6f84A |
Akr1b1 at 2.55 mgy radiation dose. |
|
108
|
316
|
6f7rA |
Akr1b1 at 0.03 mgy radiation dose. |
|
106
|
316
|
6f82A |
Akr1b1 at 1.65 mgy radiation dose. |
|
105
|
316
|
3v36A |
Aldose reductase complexed with glceraldehyde |
|
109
|
316
|
3v35A |
Aldose reductase complexed with a nitro compound |
|
103
|
315
|
3u2cA |
Aldose reductase in complex with nsaid-type inhibitor at 1.0 a resolution |
|
111
|
316
|
3t42A |
Human aldose reductase in complex with a nitrile-containing idd inhibitor |
|
108
|
316
|
3s3gA |
Crystal structure of human aldose reductase complexed with tolmetin |
|
110
|
318
|
3rx3A |
Crystal structure of human aldose reductase complexed with sulindac |
|
107
|
318
|
3rx2A |
Crystal structure of human aldose reductase complexed with sulindac sulfone |
|
107
|
318
|
3rx4A |
Crystal structure of human aldose reductase complexed with sulindac sulfide |
|
106
|
315
|
2nvdA |
Human aldose reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2) |
|
109
|
316
|
5oujA |
Crystal structure of human akr1b1 complexed with nadp+ and compound 39 |
|
104
|
316
|
5oukA |
Crystal structure of human akr1b1 complexed with nadp+ and compound 41 |
|
111
|
316
|
5ou0A |
Crystal structure of human akr1b1 complexed with nadp+ and compound 37 |
|
106
|
316
|
4ys1A |
Human aldose reductase complexed with a ligand with an idd structure (2) at 1.07 a. |
|
108
|
316
|
5ha7A |
Human aldose reductase in complex with nadp+ and wy14643 in space group p212121 |
|
109
|
316
|
4yu1A |
Human aldose reductase complexed with schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at 1.02 a |
|
114
|
316
|
4xzhA |
Crystal structure of human aldose reductase complexed with nadp+ and jf0048 |
|
104
|
316
|
4xziA |
Crystal structure of human aldose reductase complexed with nadp+ and jf0049 |
|
109
|
316
|
4qx4A |
Human aldose reductase complexed with a ligand with a new scaffold at 1.26 a |
|
108
|
314
|
4rpqA |
Human aldose reductase complexed with a ligand with an idd structure at 1.20 a (1) |
|
107
|
316
|
4qr6A |
Human aldose reductase complexed with a ligand with an idd structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 a |
|
108
|
314
|
4qxiA |
Crystal structure of human ar complexed with nadp+ and ak198 |
|
108
|
316
|
4qbxA |
Human aldose reductase complexed with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 a |
|
107
|
316
|
4puuA |
Human aldose reductase complexed with a ligand with an idd structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 a |
|
109
|
315
|
4pr4A |
Human aldose reductase complexed with schl7802 at 1.06 a |
|
111
|
316
|
4prtA |
Human aldose reductase complexed with schl12221 ({2-[5-(3-nitrophenyl)furan-2-yl]phenyl}acetic acid) at 0.96 a |
|
107
|
316
|
4puwA |
Human aldose reductase complexed with a ligand with an idd structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 a |
|
112
|
315
|
4prrA |
Human aldose reductase complexed with schl7815 ((3-[3-(5-nitrofuran-2-yl)phenyl]propanoic acid)at 1.01 a |
|
108
|
315
|
4q7bA |
Human aldose reductase complexed with a ligand with an idd structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 a |
|
106
|
314
|
4nkcA |
Human aldose reductase complexed with schl7764 at 1.12 a |
|
110
|
316
|
4lbrA |
Crystal structure of human ar complexed with nadp+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid |
|
109
|
316
|
4lbsA |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
|
109
|
316
|
4lb4A |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
|
111
|
316
|
4lauA |
Crystal structure of human ar complexed with nadp+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid |
|
108
|
316
|
4lb3A |
Crystal structure of human ar complexed with nadp+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid |
